Figure 3.
BAFF serum levels in MS samples with or without Methylprednisolone (MP) therapy positive or negative to EBV, MAP and human homologous peptides: EBV latent EBNA1400–413; (A) MAP_106c121–132; (B) MBP85–98. (C) EBV lytic BOLF1305–320; (D) MAP_402718–32; (E) IRF5424– 434. (F) P values were calculated by Dunn’s test, Graph Pad Prism 6.0 software (San Diego, CA, USA).